Search results
From DrugPedia: A Wikipedia for Drug discovery
You searched for Immunogenicity
No page title matches
There is no page titled "Immunogenicity". You can create this page.
For more information about searching DrugPedia: A Wikipedia for Drug discovery, see Help.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Page title matches
- Immunogenicity Versus Antigenicity '''Immunogenicity''' and '''antigenicity''' are related but distinct immunologic properties that sometimes are confused. Immunogenicity1 KB (162 words) - 09:16, 11 August 2008
Page text matches
- Immunogenicity Versus Antigenicity '''Immunogenicity''' and '''antigenicity''' are related but distinct immunologic properties that sometimes are confused. Immunogenicity1 KB (162 words) - 09:16, 11 August 2008
- Antigens ==Immunogenicity of Antigens== ===Factors determining immunogenicity===2 KB (214 words) - 09:55, 18 August 2008
- Vaccine ... l efficacy of plasmid DNA immunization depends on increasing the plasmid's immunogenicity while also correcting for factors involved in the specific activation of i ...21 KB (3042 words) - 07:01, 19 August 2008
- Malaria vaccine ... roblems were encountered due to low efficacy, [[reactogenicity]] and low [[immunogenicity]]. ... technology exist as it contains only 20% [[peptide]] and has low levels of immunogenicity. It also does not contain any immunodominant T-cell [[epitopes]].26 KB (3922 words) - 11:25, 25 August 2008
- Biological Target ... roblems were encountered due to low efficacy, [[reactogenicity]] and low [[immunogenicity]]. ... technology exist as it contains only 20% [[peptide]] and has low levels of immunogenicity. It also does not contain any immunodominant T-cell [[epitopes]].26 KB (3922 words) - 11:27, 25 August 2008
- Bioinformatics Databases ... epitopes, rather than a large collection of defined epitopes with varying immunogenicity should be selected for vaccines.5 KB (765 words) - 12:07, 1 September 2008
- Keyhole limpet hemocyanin ... destroy tumor cells. The KLH carrier protein is responsible for conferring immunogenicity to the tumor antigens in these vaccines The rapidly growing interest in th ...6 KB (934 words) - 07:00, 9 September 2010
- CarboDB Glycopeptidolipid antigen 1663 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (258 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1664 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (258 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1665 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (258 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1666 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (258 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1667 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (258 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1668 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (212 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1669 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (212 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1670 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (212 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1671 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (228 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1672 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (228 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1673 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (231 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1674 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (226 words) - 06:09, 8 April 2010
- CarboDB Glycopeptidolipid antigen 1675 This oligosaccharide unit is the source of the dominant immunogenicity of members of the M. avium complex, i.e., their characteristic agglutinabi ...2 KB (218 words) - 06:09, 8 April 2010
